STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer
出版年份 2019 全文链接
标题
STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 6, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-06-04
DOI
10.1038/s41419-019-1659-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- FOXO1/3: Potential suppressors of fibrosis
- (2018) Zhenlong Xin et al. AGEING RESEARCH REVIEWS
- Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression
- (2018) Fernanda Marconi Roversi et al. BIOMEDICINE & PHARMACOTHERAPY
- STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma
- (2018) Yun-ping Hu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer
- (2018) Hiroaki Kataoka et al. PATHOLOGY INTERNATIONAL
- Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?
- (2018) Vincent Prêtre et al. SEMINARS IN CANCER BIOLOGY
- Forkhead box O proteins: Crucial regulators of cancer EMT
- (2018) Zhiqiang Ma et al. SEMINARS IN CANCER BIOLOGY
- Gyneco-oncological genomics and emerging biomarkers for cancer treatment with immune-checkpoint inhibitors
- (2018) Giuseppe Curigliano SEMINARS IN CANCER BIOLOGY
- PKB/Akt-dependent regulation of inflammation in cancer
- (2018) Fengyuan Tang et al. SEMINARS IN CANCER BIOLOGY
- Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis
- (2018) Stephan Marquardt et al. SEMINARS IN CANCER BIOLOGY
- Emerging biomarkers for immune checkpoint inhibition in lung cancer
- (2018) George Cyriac et al. SEMINARS IN CANCER BIOLOGY
- PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
- (2018) Jake S. O’Donnell et al. SEMINARS IN CANCER BIOLOGY
- Cell death-based treatment of lung adenocarcinoma
- (2018) Tatiana V. Denisenko et al. Cell Death & Disease
- AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis
- (2018) Dong Liu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
- (2017) Lais Osmani et al. SEMINARS IN CANCER BIOLOGY
- Lung cancer epigenetics: From knowledge to applications
- (2017) Michaël Duruisseaux et al. SEMINARS IN CANCER BIOLOGY
- Prognostic and predictive biomarkers in breast cancer: Past, present and future
- (2017) Andrea Nicolini et al. SEMINARS IN CANCER BIOLOGY
- Pterostilbene exerts anticancer activity on non-small-cell lung cancer via activating endoplasmic reticulum stress
- (2017) Zhiqiang Ma et al. Scientific Reports
- STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling
- (2016) Zhaowen Wang et al. Scientific Reports
- Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer
- (2015) Liang Hu et al. BMC CANCER
- Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
- (2014) Peng Chen et al. BMC CANCER
- Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma
- (2013) Dongli Yue et al. EXPERIMENTAL CELL RESEARCH
- HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase
- (2013) C-H Tsai et al. ONCOGENE
- NOK/STYK1 interacts with GSK-3β and mediates Ser9 phosphorylation through activated Akt
- (2012) Jing Li et al. FEBS LETTERS
- Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screening
- (2012) Yong Qin et al. Pigment Cell & Melanoma Research
- Preclinical and Clinical Estimates of the Basal Apoptotic Rate of a Cancer Predict the Amount of Apoptosis Induced by Subsequent Proapoptotic Stimuli
- (2010) L. Zhang et al. CLINICAL CANCER RESEARCH
- Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer
- (2010) Wenjie Dong et al. INTERNATIONAL JOURNAL OF CANCER
- The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer
- (2010) Keiichiro Nakamura et al. INTERNATIONAL JOURNAL OF CANCER
- Loss of the matriptase inhibitor HAI-2 during prostate cancer progression
- (2010) Christopher Bergum et al. PROSTATE
- Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer
- (2009) Suyoun Chung et al. CANCER SCIENCE
- Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemia
- (2009) Takashi Kondoh et al. EXPERIMENTAL HEMATOLOGY
- Aberrant STYK1 expression in ovarian cancer tissues and cell lines
- (2009) Kesmic A Jackson et al. Journal of Ovarian Research
- Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer
- (2008) K. Nakamura et al. ANNALS OF ONCOLOGY
- An Epigenetic Genome-Wide Screen Identifies SPINT2 as a Novel Tumor Suppressor Gene in Pediatric Medulloblastoma
- (2008) P. N. Kongkham et al. CANCER RESEARCH
- HAI-2is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions
- (2008) Edmund Kwok-Kwan Tung et al. INTERNATIONAL JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started